|
Market Closed -
Euronext Paris
03:55:00 31/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 347.00 EUR | +0.73% |
|
-0.57% | -2.94% |
| 21/10 | Virbac: A well-done Q3 validates underlying quality |  |
| 20/10 | Virbac stock little changed despite strong update and targets now expected at the top end of the range |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VIRBAC | Veterinary Drugs | +0.73% | -0.57% | -2.94% | -2.12% | -20.69% | 3.25B |  |  | |
- Stock Market
- Stocks
- VIRP Stock
- Charts Virbac
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
